# Armata Pharmaceuticals, Inc.: Form 8-K, filed Dec 4, 2024

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 8-K
- Filed: 2024-12-04
- Accepted by EDGAR: Dec 4, 2024, 16:05 ET
- Period: 2024-12-02
- Accession: 0001104659-24-125505
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000110465924125505/tm2430081d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000110465924125505/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000110465924125505/tm2430081d1_8k.htm

Filed Dec 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-125505. Last ingested by Listed: Nov 13, 2026, 16:13 ET. No prices; not investment advice.
